Your browser doesn't support javascript.
loading
Cyclophosphamide and tucotuzumab (huKS-IL2) following first-line chemotherapy in responding patients with extensive-disease small-cell lung cancer.
Gladkov, Oleg; Ramlau, Rodryg; Serwatowski, Piotr; Milanowski, Janusz; Tomeczko, Janusz; Komarnitsky, Philip B; Kramer, Daniel; Krzakowski, Maciej J.
Afiliação
  • Gladkov O; aChelyabinsk Regional Clinical Oncology Dispensary, Chelyabinsk, Russia bDepartment and Clinic of Oncology, Poznan University of Medical Sciences, Poznan cDepartment of Chemotherapy, Alfred Sokolowski Specialized Hospital, Szczecin dDepartment of Pulmonology, Oncology and Allergology, Medical University of Lublin, Lublin eDepartment of Pulmonary Diseases, Lower Silesian Center for Pulmonary Diseases, Wroclaw fDepartment of Lung and Chest Cancers, Maria Sklodowska-Curie Institute of Oncology, War
Anticancer Drugs ; 26(10): 1061-8, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26295868
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares Idioma: En Ano de publicação: 2015 Tipo de documento: Article